Neutrophil to lymphocyte ratio predict mortality and major adverse cardiac events in acute coronary syndrome: A systematic review and meta-analysis

CH Dong, ZM Wang, SY Chen - Clinical biochemistry, 2018 - Elsevier
Objectives Neutrophil to lymphocyte ratio (NLR) might be associated with the mortality or
major adverse cardiac events (MACEs) in acute coronary syndrome (ACS) patients. We …

Current and emerging direct oral anticoagulants: state-of-the-art

G Lippi, R Gosselin, EJ Favaloro - Seminars in thrombosis and …, 2019 - thieme-connect.com
Anticoagulant drugs comprise a specific subcategory of antithrombotic agents that act to
inhibit blood coagulation at various stages, reducing clot development and ultimately …

The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an …

M Dimairo, P Pallmann, J Wason, S Todd, T Jaki… - bmj, 2020 - bmj.com
Adaptive designs (ADs) allow pre-planned changes to an ongoing trial without
compromising the validity of conclusions and it is essential to distinguish pre-planned from …

Chitosan-Based Scaffolds for the Treatment of Myocardial Infarction: A Systematic Review

B Beleño Acosta, RC Advincula, CD Grande-Tovar - Molecules, 2023 - mdpi.com
Cardiovascular diseases (CVD), such as myocardial infarction (MI), constitute one of the
world's leading causes of annual deaths. This cardiomyopathy generates a tissue scar with …

Synergistic inhibition of SARS-CoV-2 cell entry by otamixaban and covalent protease inhibitors: pre-clinical assessment of pharmacological and molecular properties

T Hempel, K Elez, N Krüger, L Raich, JH Shrimp… - Chemical …, 2021 - pubs.rsc.org
SARS-CoV-2, the cause of the COVID-19 pandemic, exploits host cell proteins for viral entry
into human lung cells. One of them, the protease TMPRSS2, is required to activate the viral …

Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?

K Huber, ER Bates, M Valgimigli, L Wallentin… - American heart …, 2014 - Elsevier
Mortality and morbidity in acute coronary syndromes (ACSs), caused principally by plaque
erosion or rupture leading to thrombus formation and myocardial ischemia, have been …

New approaches to inhibiting platelets and coagulation

JP Depta, DL Bhatt - Annual review of pharmacology and …, 2015 - annualreviews.org
Ischemic heart disease and stroke are major causes of death and morbidity worldwide.
Coronary and cerebrovascular events are a consequence of thrombus formation caused by …

Timing of Angiography and Outcomes in High-Risk Patients With Non–ST-Segment–Elevation Myocardial Infarction Managed Invasively: Insights From the TAO Trial …

P Deharo, G Ducrocq, C Bode, M Cohen, T Cuisset… - Circulation, 2017 - Am Heart Assoc
Background: In patients with non–ST-segment–elevation myocardial infarction (NSTEMI)
and GRACE (Global Registry of Acute Coronary Events) score> 140, coronary angiography …

[HTML][HTML] Anticoagulant therapy for acute coronary syndromes

ENC Onwordi, A Gamal, A Zaman - Interventional cardiology …, 2018 - ncbi.nlm.nih.gov
Anticoagulation in conjunction with antiplatelet therapy is central to the management of
acute coronary syndromes (ACS). When used effectively it is associated with a reduction in …

Actualización en cardiopatía isquémica y cuidados críticos cardiológicos

F Marín, Ó Díaz-Castro, JM Ruiz-Nodar… - Revista Española de …, 2014 - Elsevier
Actualización en cardiopatía isquémica y cuidados críticos cardiológicos - ScienceDirect
Skip to main contentSkip to article Elsevier logo Journals & Books Search RegisterSign in …